Allan Kaspar

3.8k total citations · 1 hit paper
16 papers, 1.3k citations indexed

About

Allan Kaspar is a scholar working on Molecular Biology, Microbiology and Immunology. According to data from OpenAlex, Allan Kaspar has authored 16 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Microbiology and 4 papers in Immunology. Recurrent topics in Allan Kaspar's work include Antimicrobial Peptides and Activities (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Invertebrate Immune Response Mechanisms (2 papers). Allan Kaspar is often cited by papers focused on Antimicrobial Peptides and Activities (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Invertebrate Immune Response Mechanisms (2 papers). Allan Kaspar collaborates with scholars based in United States, Spain and Germany. Allan Kaspar's co-authors include Janice M. Reichert, Alan M. Krensky, Dennis A. Hanson, Alberto Anel, Francis R. Poulain, Susana Gamen, Javier Naval, Carol Clayberger, Satoshi Okada and Shu-Chen Lyu and has published in prestigious journals such as The Journal of Immunology, Neurology and Scientific Reports.

In The Last Decade

Allan Kaspar

16 papers receiving 1.3k citations

Hit Papers

Future directions for peptide therapeutics development 2013 2026 2017 2021 2013 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Future directions for peptide therapeutics development
    2013 597 citations Allan Kaspar, Janice M. Reichert Drug Discovery Today profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allan Kaspar United States 11 680 389 369 190 112 16 1.3k
Jlenia Brunetti Italy 22 696 1.0× 163 0.4× 488 1.3× 103 0.5× 49 0.4× 59 1.2k
Robert A. Cordfunke Netherlands 18 722 1.1× 199 0.5× 619 1.7× 217 1.1× 42 0.4× 37 1.4k
Wuyuan Lu United States 18 611 0.9× 295 0.8× 213 0.6× 150 0.8× 109 1.0× 30 1.1k
Björn Walse Sweden 22 882 1.3× 908 2.3× 327 0.9× 263 1.4× 99 0.9× 49 2.0k
Su‐Jin Kang South Korea 18 655 1.0× 214 0.6× 398 1.1× 81 0.4× 131 1.2× 52 1.1k
Liping Liu China 18 641 0.9× 637 1.6× 199 0.5× 55 0.3× 90 0.8× 39 1.5k
Christian Kleist Germany 22 511 0.8× 342 0.9× 154 0.4× 61 0.3× 66 0.6× 56 1.3k
Anna Lucia Tornesello Italy 13 727 1.1× 186 0.5× 268 0.7× 45 0.2× 111 1.0× 24 1.1k
Loı̈c Martin France 23 660 1.0× 523 1.3× 95 0.3× 72 0.4× 121 1.1× 56 1.6k
Michel Kaczorek France 18 713 1.0× 346 0.9× 88 0.2× 53 0.3× 72 0.6× 32 1.3k

Countries citing papers authored by Allan Kaspar

Since Specialization
Citations

This map shows the geographic impact of Allan Kaspar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan Kaspar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan Kaspar more than expected).

Fields of papers citing papers by Allan Kaspar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan Kaspar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan Kaspar. The network helps show where Allan Kaspar may publish in the future.

Co-authorship network of co-authors of Allan Kaspar

This figure shows the co-authorship network connecting the top 25 collaborators of Allan Kaspar. A scholar is included among the top collaborators of Allan Kaspar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan Kaspar. Allan Kaspar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Powers, Samantha K., Carlos J. Miranda, Lyndsey Braun, et al.. (2019). Rett syndrome gene therapy improves survival and ameliorates behavioral phenotypes in MeCP2 null (S51.002). Neurology. 92(15_supplement). 5 indexed citations
2.
Thomsen, Gretchen M., Ching-Chyuan Hsieh, Steven M. Solano, et al.. (2019). O.24Biodistribution of onasemnogene abeparvovec (AVXS-101) DNA, mRNA, and SMN protein in human tissue. Neuromuscular Disorders. 29. S122–S123. 2 indexed citations
3.
Thomsen, Gretchen M., Shibi Likhite, Sarah Corcoran, et al.. (2019). Intrathecal AAV9-SOD1-shRNA Administration for Amyotrophic Lateral Sclerosis (S5.003). Neurology. 92(15_supplement). 2 indexed citations
4.
Liu, Dingguo, Haim Moskowitz, Anouk Dirksen, et al.. (2013). The Effect of Molecular Weight, PK, and Valency on Tumor Biodistribution and Efficacy of Antibody-Based Drugs. Translational Oncology. 6(5). 562–IN6. 32 indexed citations
5.
Tong, Huimin, Lei Zhang, Allan Kaspar, et al.. (2013). Peptide-Conjugation Induced Conformational Changes in Human IgG1 Observed by Optimized Negative-Staining and Individual-Particle Electron Tomography. Scientific Reports. 3(1). 1089–1089. 29 indexed citations
6.
Kaspar, Allan & Janice M. Reichert. (2013). Future directions for peptide therapeutics development. Drug Discovery Today. 18(17-18). 807–817. 597 indexed citations breakdown →
7.
Zhang, Lei, Allan Kaspar, Gary Woodnutt, & Gang Ren. (2010). Monitoring the Structural Changes of Conjugated Antibodies by High-Resolution Electron Microscopy and Individual-Particle Electron Tomography. Biophysical Journal. 98(3). 440a–441a. 7 indexed citations
8.
Kaspar, Allan, Satoshi Okada, Jayant Kumar, et al.. (2001). A Distinct Pathway of Cell-Mediated Apoptosis Initiated by Granulysin. The Journal of Immunology. 167(1). 350–356. 120 indexed citations
9.
Pardo, Julián, Patricia Pérez‐Galán, Susana Gamen, et al.. (2001). A Role of the Mitochondrial Apoptosis-Inducing Factor in Granulysin-Induced Apoptosis. The Journal of Immunology. 167(3). 1222–1229. 95 indexed citations
10.
Hata, Atsuko, Leigh Zerboni, Marvin Sommer, et al.. (2001). Granulysin Blocks Replication of Varicella-Zoster Virus and Triggers Apoptosis of Infected Cells. Viral Immunology. 14(2). 125–133. 44 indexed citations
11.
Wang, Zhuo, Allan Kaspar, Dennis A. Hanson, et al.. (2000). Bactericidal and Tumoricidal Activities of Synthetic Peptides Derived from Granulysin. The Journal of Immunology. 165(3). 1486–1490. 108 indexed citations
12.
Hanson, Dennis A., Allan Kaspar, Francis R. Poulain, & Alan M. Krensky. (1999). Biosynthesis of granulysin, a novel cytolytic molecule. Molecular Immunology. 36(7). 413–422. 91 indexed citations
13.
Kaspar, Allan, Dennis A. Hanson, Alan M. Krensky, Samuel Hawgood, & Francis R. Poulain. (1999). Granulysin-Induced Lysis of Membranes Depends on pH and the Net Charge of Phospholipids. Pediatric Research. 45(4, Part 2 of 2). 11A–11A. 3 indexed citations
14.
Gamen, Susana, Dennis A. Hanson, Allan Kaspar, et al.. (1998). Granulysin-Induced Apoptosis. I. Involvement of at Least Two Distinct Pathways. The Journal of Immunology. 161(4). 1758–1764. 116 indexed citations
15.
Kaspar, Allan, Heinrich Brinkmeier, & R. R�del. (1994). Local anaesthetic-like effect of interleukin-2 on muscular Na+ channels: no evidence for involvement of the IL-2 receptor. Pflügers Archiv - European Journal of Physiology. 426(1-2). 61–67. 22 indexed citations
16.
Brinkmeier, Heinrich, et al.. (1992). Interleukin-2 inhibits sodium currents in human muscle cells. Pflügers Archiv - European Journal of Physiology. 420(5-6). 621–623. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jlenia Brunetti Breakdown of academic impact, for papers by Robert A. Cordfunke Breakdown of academic impact, for papers by Wuyuan Lu Breakdown of academic impact, for papers by Björn Walse Breakdown of academic impact, for papers by Su‐Jin Kang Breakdown of academic impact, for papers by Liping Liu Breakdown of academic impact, for papers by Christian Kleist Breakdown of academic impact, for papers by Anna Lucia Tornesello Breakdown of academic impact, for papers by Loı̈c Martin Breakdown of academic impact, for papers by Michel Kaczorek
Rankless by CCL
2026